You are not logged in.

Supply of Metoprolol Succinate and Tartrate to DHB Hospitals and/or Community Pharmacies

Details

Tender Closed
RFx ID : 10950543
Tender Name : Supply of Metoprolol Succinate and Tartrate to DHB Hospitals and/or Community Pharmacies
Reference # :
Open Date : Monday, 20 April 2015 11:30 AM (Pacific/Auckland UTC+12:00)
Close Date  : Monday, 18 May 2015 4:00 PM (Pacific/Auckland UTC+12:00)
Tender Type : Request for Tenders (RFT)
Tender Coverage : Sole Agency  [?]
Categories :
  • 51120000 - Cardiovascular drugs
Regions:
  • New Zealand
Exemption Reason : None
Required Pre-qualifications : None
Contact : Chris Little
chris.little@pharmac.govt.nz
+64 (0)4 901 3264
Alternate Physical Delivery Address  :
Alternate Physical Fax Number  :
Agency Address :
Overview

PHARMAC currently lists and fully funds metoprolol succinate & metoprolol tartrate brands in Section B and Section H of the Pharmaceutical Schedule, without restriction.
All presentations of each chemical have Sole Supply Status as well as Hospital Sole Supply expiring 30 June 2015.

Metoprolol succinate and tartrate are Beta-adrenoceptor blocking agents, or beta-blockers as they are more commonly called, used predominantly in the treatment of such conditions as hypertension, angina and cardiac arrhythmias.

PHARMAC is seeking responses for community and hospital sole supply (Sections B and H of the Pharmaceutical Schedule) to run until 30 June 2018, for each of the products listed in Schedule Two.
For clarification, in accordance with clauses 2.3 to 2.6 of Schedule Three, you may submit:

• Individual Tender Bids,
• Aggregated Tender Bids,
• Combined Community/Hospital Tender Bids,
• Aggregated Combined Community/Hospital Tender Bids,
• If a bid is submitted for metoprolol succinate then it is submitted for all strengths of metoprolol succinate currently listed,
• If a bid is submitted for oral metoprolol tartrate then it is submitted for all strengths of oral metoprolol tartrate currently listed,
• It is preferable but not essential that metoprolol succinate is supplied in either 90 tablet or 30 tablet pack sizes
.
For the avoidance of doubt and In accordance with clause 1.15 of Schedule Two, PHARMAC is not willing to consider Tender Bids that include Rebates in respect of Tender Items as part of this RFT. Accordingly, you may not submit a bid for a Tender Item that includes a Rebate.

RFx Outcome

This tender has been awarded to:

  • AFT Pharmaceuticals Ltd.
  • Apotex NZ Ltd

Further Award Information:
Please find attached the award notices for details.

Award Date: Friday, 15 January 2016 (Pacific/Auckland UTC+13:00)
Date RFx was completed/updated: Monday, 18 May 2015 4:02 PM (Pacific/Auckland UTC+12:00)